PLSE

Healthcare Medical Instruments & Supplies

Pulse Biosciences, Inc.

$48.72

-1.03 -2.07% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 7, 2026, live at 12:45 PM ET	48.72

Key Stats

Market Cap

3.47B

Avg Volume

499,789

EPS

-$1.18

52W High

$58.90

52W Low

$12.56

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-41.64

P/B Ratio

34.68

P/S Ratio

2932.35

EV/EBITDA

-41.80

EV/Revenue

2914.30

Margins

Gross Margin 0.3%

Operating Margin (5823.0%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(78.5%)

Return on Assets

(44.3%)

Liquidity & Leverage

Current Ratio

9.63

Quick Ratio

9.27

Debt / Equity

0.07

Total Cash

101.62M

Total Debt

6.77M

About

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.